基于标准化测试的乳腺筛查表现在COVID-19封锁期间与封锁期间外的比较
该回顾性研究分析了2015至2022年英格兰所有完成基于数字乳腺X线摄影的PERFORMS方案的乳腺筛查阅读者的表现数据,共4906名阅读者参与8次PERFORMS方案。结果显示癌症检出率(敏感度)和正确返回筛查率(特异度)随方案显著变化,封锁期间实施的方案中癌症检出率与正确返回筛查率之差显著高于其他所有方案。
要点
- 封锁期间PERFORMS测试中乳腺筛查阅读者表现为敏感度显著升高、特异度显著降低。
- 癌症检出率(H(7)=775.56,p<.00001)和正确返回筛查率(H(7)=401.13,p<.00001)随方案显著变化。
- 封锁期间方案中癌症检出率与正确返回筛查率之差显著高于其他所有方案(p<.05,Bonferroni校正)。
核心结论
- 封锁期间实施的PERFORMS测试集评估方案中,乳腺筛查阅读者的表现特征为敏感度显著升高、特异度显著降低,与COVID-19前和封锁后其他测试中的表现相比。
研究设计与样本
- 回顾性研究,获取2015至2022年英格兰所有完成基于数字乳腺X线摄影的PERFORMS方案的乳腺筛查阅读者的表现数据,共4906名阅读者参与8次PERFORMS方案。
诊断标准与关键数值
- 癌症检出率(敏感度)和正确返回筛查率(特异度)在每次PERFORMS方案中为每名乳腺筛查阅读者计算。
- 癌症检出率随方案显著变化(H(7)=775.56,p<.00001)。
- 正确返回筛查率随方案显著变化(H(7)=401.13,p<.00001)。
- 封锁期间实施方案中癌症检出率与正确返回筛查率之差显著高于其他所有方案(p<.05,Bonferroni校正)。
局限性
- 原文未报告局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
PURPOSE: In the UK, the COVID-19 pandemicand the resulting lockdown significantly impacted routine breast screening and led to reduced case volumes for breast screening readers. The aim of the study was to evaluate whether breast screening performance on a test-set based assessment scheme (PERFORMS) varied over time, in association with the lockdown period.
METHOD: In this retrospective study, performance data were obtained for all breast cancer screening readers in England who completed the PERFORMS schemes based on digital mammography (from 2015 to 2022). Cancer detection (sensitivity), correct return to screen (specificity) and the difference between the sensitivity and specificity were calculated for each breast screener in each PERFORMS scheme.
RESULTS: During the study period, 4906 readers participated in eight PERFORMS schemes. Both the cancer detection (H(7) = 775.56, p <.00001) and correct return to screen rate (H(7) = 401.13, p <.00001) varied significantly by scheme. The difference between cancer detection and correct return to screen rate in the scheme administered during the lockdown period was significantly higher than in all other schemes (p <.05, Bonferroni correction applied).
CONCLUSIONS: The performance of breast screeners on the PERFORMS test-set based assessment scheme which was administered during the lockdown period, was characterised by markedly high sensitivity and low specificity when compared to their performance on other tests taken pre-COVID and following the lockdown.
引用
- Michalopoulou E, Pugalenthi PP, Darker I, et al. A comparison of breast screening performance based on a standardised test, during and outside of the COVID-19 lockdown period. Eur J Radiol. 2023. PMID: 37778148. doi:10.1016/j.ejrad.2023.111117
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。